Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/25690
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-04-11T07:23:17Z | - |
dc.date.available | 2022-04-11T07:23:17Z | - |
dc.date.issued | 2012-01 | - |
dc.identifier.citation | Çelebi, S. vd. (2012). "Neonatal candidiasis: Results of an 8 year study". Pediatrics International, 54(3), 341-349. | en_US |
dc.identifier.issn | 1328-8067 | - |
dc.identifier.issn | 1442-200X | - |
dc.identifier.uri | https://doi.org/10.1111/j.1442-200X.2012.03574.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/full/10.1111/j.1442-200X.2012.03574.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/25690 | - |
dc.description.abstract | Background: The aim of the present study was to evaluate the risk factors, demographic features, treatment and clinical outcome associated with candidemia in a neonatal intensive care unit (NICU) within an 8 year period. Methods: The data of infants who were diagnosed as having candidemia, were evaluated. Results: Between January 2000 and December 2007, a total of 28 candidemia episodes were identified in 28 infants. A 1.1% candidemia incidence was documented in the neonatal intensive care unit (NICU). The species most frequently causing candidemia were Candida parapsilosis (57.1%), followed by C. albicans (42.9%). The main predisposing factors for candidemia with C. parapsilosis included presence of maternal pre-eclampsia, prematurity, prolonged mechanical ventilation, prolonged total parenteral nutrition and presence of jaundice. Retinopathy of prematurity and bronchopulmonary dysplasia were the most frequently seen underlying illnesses in infants with C. parapsilosis. In the present study, 13 infants (46.4%) had evidence of organ dissemination. The mortality rate was 42.8% in infants with candidemia. Mean leukocyte counts and mean C-reactive protein were significantly higher in neonates who died compared with those who survived. Conclusion: Candida parapsilosis (57.1%) was the leading causative organism, followed by C. albicans (42.9%) in infants. The rate of organ dissemination in the present cases was high. The mortality rate was 42.8% in infants with candidemia. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pediatrics | en_US |
dc.subject | Infants | en_US |
dc.subject | Neonatal intensive care unit | en_US |
dc.subject | Risk factors for candidemia | en_US |
dc.subject | Blood-stream infections | en_US |
dc.subject | Intensive-care-unit | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Horizontal transmission | en_US |
dc.subject | Candidemia | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Sepsis | en_US |
dc.subject | Therapy | en_US |
dc.subject | Susceptibility | en_US |
dc.subject.mesh | Candida | en_US |
dc.subject.mesh | Candidemia | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant, newborn | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prospective studies | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Time factors | en_US |
dc.title | Neonatal candidiasis: Results of an 8 year study | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000304470000014 | tr_TR |
dc.identifier.scopus | 2-s2.0-84861599755 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı/Çocuk Enfeksiyon Hastalıkları Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı/Neonatoloji Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-4803-8206 | tr_TR |
dc.identifier.startpage | 341 | tr_TR |
dc.identifier.endpage | 349 | tr_TR |
dc.identifier.volume | 54 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Pediatrics International | en_US |
dc.contributor.buuauthor | Çelebi, Solmaz | - |
dc.contributor.buuauthor | Hacımustafaoğlu, Mustafa | - |
dc.contributor.buuauthor | Köksal, Nilgün | - |
dc.contributor.buuauthor | Özkan, Hilal | - |
dc.contributor.buuauthor | Çetinkaya, Merih | - |
dc.contributor.buuauthor | Ener, Beyza | - |
dc.contributor.researcherid | AAG-8393-2021 | tr_TR |
dc.contributor.researcherid | AAG-8523-2021 | tr_TR |
dc.identifier.pubmed | 22320707 | tr_TR |
dc.subject.wos | Pediatrics | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 7006095295 | tr_TR |
dc.contributor.scopusid | 6602154166 | tr_TR |
dc.contributor.scopusid | 7003323615 | tr_TR |
dc.contributor.scopusid | 16679325400 | tr_TR |
dc.contributor.scopusid | 23994946300 | tr_TR |
dc.contributor.scopusid | 15053025300 | tr_TR |
dc.subject.scopus | Invasive Candidiasis; Fluconazole; Systemic Mycosis | en_US |
dc.subject.emtree | Amikacin | en_US |
dc.subject.emtree | Amphotericin b deoxycholate | en_US |
dc.subject.emtree | Amphotericin b lipid complex | en_US |
dc.subject.emtree | Ampicillin | en_US |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | Carbapenem | en_US |
dc.subject.emtree | Cefotaxime | en_US |
dc.subject.emtree | Ceftazidime | en_US |
dc.subject.emtree | Fluconazole | en_US |
dc.subject.emtree | Flucytosine | en_US |
dc.subject.emtree | Gentamicin | en_US |
dc.subject.emtree | Vancomycin | en_US |
dc.subject.emtree | Apnea | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Artificial ventilation | en_US |
dc.subject.emtree | Brain | en_US |
dc.subject.emtree | Candida albicans | en_US |
dc.subject.emtree | Candida parapsilosis | en_US |
dc.subject.emtree | Candidiasis | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Demography | en_US |
dc.subject.emtree | Disease exacerbation | en_US |
dc.subject.emtree | Drug substitution | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Fever | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Incidence | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Infant mortality | en_US |
dc.subject.emtree | Jaundice | en_US |
dc.subject.emtree | Kidney | en_US |
dc.subject.emtree | Klebsiella pneumoniae | en_US |
dc.subject.emtree | Leukocyte count | en_US |
dc.subject.emtree | Lung dysplasia | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Newborn | en_US |
dc.subject.emtree | Newborn disease | en_US |
dc.subject.emtree | Newborn intensive care | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Parenteral nutrition | en_US |
dc.subject.emtree | Peritoneal cavity | en_US |
dc.subject.emtree | Preeclampsia | en_US |
dc.subject.emtree | Prematurity | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Prospective study | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | Retrolental fibroplasia | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Staphylococcus epidermidis | en_US |
dc.subject.emtree | Stomach distension | en_US |
dc.subject.emtree | Tachypnea | en_US |
dc.subject.emtree | Treatment duration | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.